Agilent Technologies Revenue by End Market

History

Date	Pharmaceutical and Biopharmaceutical	Chemicals and Advanced Materials	Diagnostics and Clinical	Food	Academia and Government
Jul 31, 2024	2.24B	1.49B	945.00M	596.00M	567.00M
Apr 30, 2024	2.29B	1.51B	944.00M	603.00M	585.00M
Jan 31, 2024	2.36B	1.53B	955.00M	625.00M	605.00M
Oct 31, 2023	2.43B	1.54B	966.00M	628.00M	601.00M
Jul 31, 2023	2.52B	1.59B	975.00M	643.00M	601.00M
Apr 30, 2023	2.58B	1.60B	968.00M	643.00M	594.00M
Jan 31, 2023	2.55B	1.55B	959.00M	619.00M	581.00M
Oct 31, 2022	2.52B	1.52B	963.00M	617.00M	576.00M
Jul 31, 2022	2.43B	1.45B	964.00M	597.00M	579.00M
Apr 30, 2022	2.36B	1.40B	972.00M	589.00M	578.00M
Jan 31, 2022	2.31B	1.37B	964.00M	596.00M	575.00M
Oct 31, 2021	2.23B	1.33B	937.00M	600.00M	576.00M
Jul 31, 2021	2.12B	1.29B	906.00M	599.00M	574.00M
Apr 30, 2021	1.98B	1.22B	842.00M	579.00M	555.00M
Jan 31, 2021	1.85B	1.17B	809.00M	549.00M	527.00M
Oct 31, 2020	1.75B	1.15B	787.00M	517.00M	526.00M
Jul 31, 2020	1.69B	1.14B	779.00M	494.00M	516.00M
Apr 30, 2020	1.67B	1.17B	799.00M	487.00M	500.00M
Jan 31, 2020	1.64B	1.20B	792.00M	487.00M	499.00M
Oct 31, 2019	1.60B	1.20B	785.00M	486.00M	474.00M

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.